Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

NCT04152486 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
20426
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators